<?xml version='1.0' encoding='utf-8'?>
<document id="17504225"><sentence text="A pharmacokinetic interaction between clarithromycin and sirolimus in kidney transplant recipient."><entity charOffset="38-52" id="DDI-PubMed.17504225.s1.e0" text="clarithromycin" /><entity charOffset="57-66" id="DDI-PubMed.17504225.s1.e1" text="sirolimus" /><pair ddi="false" e1="DDI-PubMed.17504225.s1.e0" e2="DDI-PubMed.17504225.s1.e0" /><pair ddi="false" e1="DDI-PubMed.17504225.s1.e0" e2="DDI-PubMed.17504225.s1.e1" /></sentence><sentence text="Bacterial infection is a frequent event in renal transplant recipients and often requires the use of antimicrobial agents" /><sentence text=" In this paper it is reported an evidence of pharmacokinetic interaction between clarithromycin and sirolimus in a kidney transplanted woman, suffering from pulmonary infection sustained by a bacterial pathogen, in particular Hemophilus Influenzae"><entity charOffset="81-95" id="DDI-PubMed.17504225.s3.e0" text="clarithromycin" /><entity charOffset="100-109" id="DDI-PubMed.17504225.s3.e1" text="sirolimus" /><pair ddi="false" e1="DDI-PubMed.17504225.s3.e0" e2="DDI-PubMed.17504225.s3.e0" /><pair ddi="false" e1="DDI-PubMed.17504225.s3.e0" e2="DDI-PubMed.17504225.s3.e1" /></sentence><sentence text=" In the present case report, the concomitant administration of clarithromycin and sirolimus determined impressive increase of sirolimus trough blood concentrations from 6"><entity charOffset="63-77" id="DDI-PubMed.17504225.s4.e0" text="clarithromycin" /><entity charOffset="82-91" id="DDI-PubMed.17504225.s4.e1" text="sirolimus" /><entity charOffset="126-135" id="DDI-PubMed.17504225.s4.e2" text="sirolimus" /><pair ddi="false" e1="DDI-PubMed.17504225.s4.e0" e2="DDI-PubMed.17504225.s4.e0" /><pair ddi="false" e1="DDI-PubMed.17504225.s4.e0" e2="DDI-PubMed.17504225.s4.e1" /><pair ddi="false" e1="DDI-PubMed.17504225.s4.e0" e2="DDI-PubMed.17504225.s4.e2" /><pair ddi="false" e1="DDI-PubMed.17504225.s4.e1" e2="DDI-PubMed.17504225.s4.e1" /><pair ddi="false" e1="DDI-PubMed.17504225.s4.e1" e2="DDI-PubMed.17504225.s4.e2" /></sentence><sentence text="2 up to 54 ng/mL and this increase was associated with an acute impairment of renal function, almost completely reversed upon both drugs discontinuation" /><sentence text=" This drug-drug interaction is due to a likely inhibition of activity of both cytochrome P450 3A4 and P-glycoprotein" /><sentence text=" Although this interaction could be predicted, it represents the first reported clinical evidence" /><sentence text="" /></document>